Business Description
Solid Biosciences Inc
NAICS : 325411
SIC : 2836
ISIN : US83422E1055
Description
Financial Strength
7/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 4.71 | |||||
Equity-to-Asset | 0.77 | |||||
Debt-to-Equity | 0.21 | |||||
Debt-to-EBITDA | -0.26 | |||||
Interest Coverage | N/A | |||||
Piotroski F-Score | 3/9 | |||||
WACC vs ROIC |
Growth Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year EBITDA Growth Rate | 40.1 | |||||
3-Year EPS without NRI Growth Rate | 42.1 | |||||
3-Year FCF Growth Rate | 33.8 | |||||
3-Year Book Growth Rate | -35.7 |
Momentum Rank
3/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 19.9 | |||||
9-Day RSI | 28.92 | |||||
14-Day RSI | 37.64 | |||||
6-1 Month Momentum % | 483.93 | |||||
12-1 Month Momentum % | 159.52 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 8.94 | |||||
Quick Ratio | 8.94 | |||||
Cash Ratio | 8.52 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -53.3 | |||||
Shareholder Yield % | -1.86 |
Profitability Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
ROE % | -57.84 | |||||
ROA % | -45.97 | |||||
ROIC % | -229.08 | |||||
ROC (Joel Greenblatt) % | -292.78 | |||||
ROCE % | -54.6 |
GF Value Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PB Ratio | 1.61 | |||||
Price-to-Tangible-Book | 1.61 | |||||
EV-to-EBIT | -2.62 | |||||
EV-to-EBITDA | -2.68 | |||||
EV-to-FCF | -2.85 | |||||
Price-to-Net-Current-Asset-Value | 2.23 | |||||
Price-to-Net-Cash | 2.39 | |||||
Earnings Yield (Greenblatt) % | -38.17 | |||||
FCF Yield % | -25.37 |